5 October 2016Africa

LSIPR 50 2016: Florence Wambugu and Feng Zhang

Name: Florence Wambugu

Organisation: Africa Harvest Biotech Foundation International

Position: Founder, director and chief executive

A plant pathologist specialising in virology and genetic engineering, Florence Wambugu has been the director and chief executive of Africa Harvest Biotech Foundation International, based in Kenya, since 2002. Over the years Wambugu has devoted her time to many research projects including working as African regional director for the International Service for the Acquisition of Agri-biotech Applications.

Africa Harvest’s goal is to promote innovation and develop technology-based models that enable rural communities to engage in sustainable agricultural farming, ultimately reducing rural poverty and malnutrition throughout Africa.

Wambugu is an advocate for how biotech investment in Africa could increase food production in the continent and is the co-author and publisher of “Modifying Africa: How Biotechnology Can Benefit the Poor”. Under her direction, Africa Harvest and its collaborative organisations were awarded $18.6 million from the Bill & Melinda Gates Foundation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
20 September 2017   Feng Zhang, one of the pioneers of CRISPR technology, has been announced as the 2017 recipient of the $500,000 Lemelson-MIT Prize, which honours outstanding inventors.

More on this story

Americas
20 September 2017   Feng Zhang, one of the pioneers of CRISPR technology, has been announced as the 2017 recipient of the $500,000 Lemelson-MIT Prize, which honours outstanding inventors.

More on this story

Americas
20 September 2017   Feng Zhang, one of the pioneers of CRISPR technology, has been announced as the 2017 recipient of the $500,000 Lemelson-MIT Prize, which honours outstanding inventors.